Affiliation:
1. Eye Microsurgery Ekaterinburg Center
2. Clinical and Diagnostic Center
Abstract
This article is a continuation of a series of publications on the results of an experimental study on the possibilities of using quantum dots, as well as bioconjugates based on them as a promising treatment for inflammatory diseases of the eye. Of the whole variety of microorganisms, Pseudomonas aeruginosa (Pa) is the most formidable pathogen, leading to pronounced, sometimes fatal, changes throughout the body in general, and in the eye in particular, in connection with which it receives close attention from bacteriologists and specialists dealing with the treatment of pathologies caused by this microorganism. Now, the search for effective methods to combat this pathogen is one of the priorities of world health care.This article presents an analysis of the anti-infectious activity of bioconjugates based on quantum dots KTCdTe / CdMPA710 and KTInP / ZnSe / ZnS650 in synergy with III generation cephalosporin (Cefotaxin) against nosocomial Pa strains. Cultures of microorganisms, in the amount of 30 Petri dishes, were incubated in a thermostat at 350C for 18 hours (in the dark and under a source of photoexcitation). As a source of photoexcitation (the emission spectrum of the source corresponded to the absorption spectrum of QDs), we used an LED strip connected to an uninterruptible power supply battery placed in a thermostat. Evaluation of the effectiveness of the impact was carried out using the disk-diffusion method with the measurement of effective growth retardation zones (GRZ). According to the results of the study, it was revealed that the use of the obtained bioconjugate (QD + AB) significantly increases the ZZR.
Publisher
PE Polunina Elizareta Gennadievna
Reference17 articles.
1. Egorova O.N., Brusina E.B., Grigoriev E.V. Epidemiology and prevention of Pseudomonas aeruginosa. Federal clinical guidelines. Moscow, 2014. 82 p. (In Russ.).
2. Barry P., Cordoves L., Gardner S. ESCRS Guidelines for Prevention and Treatment of Endopthalmitis Following Cataract Surgery. Co Dublin: Temple House, Temple Road, Blackrock, 2013. P. 3–5.
3. Friling E., Lundström M., Stenevi U., Montan P. Six-year incidence of endophthalmitis after cataract surgery: Swedish national study. J Cataract Refract Surg. 2013;39:15–21. DOI: 10.1016/j.jcrs.2012.10.037
4. Eifrig C.W.G., Scott I.U., Miller D., Flynn H.W., Jr. Endophthalmitis caused by Pseudomonas aeruginosa. Ophthalmology. 2003;110(9):1714–1717. DOI: 10.1016/ S0161-6420(03)00572-4
5. Schimel A.M., Miller D., Flynn H.W., Jr. Endophthalmitis isolates and antibiotic susceptibilities: a 10-year review of culture-proven cases. Am J Ophthalmol. 2013;156(1):50–52.e1. DOI: 10.1016/j.ajo.2013.01.027
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献